Metformin: from antidiabetic to cancer therapeutic
Epidemiology studies have found that type 2 diabetics treated with metformin are at a lower risk for developing cancer. It was speculated that the lowered risk might be attributed metformin's indirect physiological effect of lowering blood insulin levels, which is the opposite of many other a...
| Main Author: | |
|---|---|
| Language: | en_US |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/15304 |